Praxis Precision Medicines, Inc. (PRAX)

Nasdaq · Healthcare · Biotechnology
$300.43-3.37%As of 2026-11-22 · USD
Last session low $298.54Last session high $314.15
52-week low $167.3252-week high $392.70
Market cap
$8.40B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)54.0In the neutral range (30 to 70)
MACD (12, 26, 9)9.08Above its signal line (8.51); histogram 0.57
Bollinger %B (20, 2)51%Inside the bands (249.77 to 348.62)
SMA 20299.20Price is 0.4% above
SMA 50286.24Price is 5.0% above
SMA 200314.56Price is 4.5% below
ATR (20)5.75% of priceAverage true range per day
52-week position59%In the middle of the 167.32 to 392.70 range

About Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance in the United States.

Latest fiscal yearEnded 2024-12-31: revenue of $8.55M and an operating margin of -2340.3%.

More in Biotechnology